Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Oreste Ghisalba - ein Nachruf.

Gygax D.

Chimia (Aarau). 2019 Feb 27;73(1):99-100. doi: 10.2533/chimia.2019.99. No abstract available.

PMID:
30814013
2.

Synthetic single domain antibodies for the conformational trapping of membrane proteins.

Zimmermann I, Egloff P, Hutter CA, Arnold FM, Stohler P, Bocquet N, Hug MN, Huber S, Siegrist M, Hetemann L, Gera J, Gmür S, Spies P, Gygax D, Geertsma ER, Dawson RJ, Seeger MA.

Elife. 2018 May 24;7. pii: e34317. doi: 10.7554/eLife.34317.

3.

Oxidation of M252 but not M428 in hu-IgG1 is responsible for decreased binding to and activation of hu-FcγRIIa (His131).

Cymer F, Thomann M, Wegele H, Avenal C, Schlothauer T, Gygax D, Beck H.

Biologicals. 2017 Nov;50:125-128. doi: 10.1016/j.biologicals.2017.09.006. Epub 2017 Oct 5.

4.

Targeted screening of succinic semialdehyde dehydrogenase deficiency (SSADHD) employing an enzymatic assay for γ-hydroxybutyric acid (GHB) in biofluids.

Wernli C, Finochiaro S, Volken C, Andresen-Streichert H, Buettler A, Gygax D, Salomons GS, Jansen EE, Ainslie GR, Vogel KR, Gibson KM.

Mol Genet Metab Rep. 2016 Aug 17;11:81-89. doi: 10.1016/j.ymgmr.2016.07.009. eCollection 2017 Jun.

5.

Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.

Tokheim C, Bhattacharya R, Niknafs N, Gygax DM, Kim R, Ryan M, Masica DL, Karchin R.

Cancer Res. 2016 Jul 1;76(13):3719-31. doi: 10.1158/0008-5472.CAN-15-3190. Epub 2016 Apr 28.

6.

Assessing the Pathogenicity of Insertion and Deletion Variants with the Variant Effect Scoring Tool (VEST-Indel).

Douville C, Masica DL, Stenson PD, Cooper DN, Gygax DM, Kim R, Ryan M, Karchin R.

Hum Mutat. 2016 Jan;37(1):28-35. doi: 10.1002/humu.22911. Epub 2015 Oct 26.

7.

Functional interactions between NURF and Ctcf regulate gene expression.

Qiu Z, Song C, Malakouti N, Murray D, Hariz A, Zimmerman M, Gygax D, Alhazmi A, Landry JW.

Mol Cell Biol. 2015 Jan;35(1):224-37. doi: 10.1128/MCB.00553-14. Epub 2014 Oct 27.

8.

The sphingolipid receptor S1PR2 is a receptor for Nogo-a repressing synaptic plasticity.

Kempf A, Tews B, Arzt ME, Weinmann O, Obermair FJ, Pernet V, Zagrebelsky M, Delekate A, Iobbi C, Zemmar A, Ristic Z, Gullo M, Spies P, Dodd D, Gygax D, Korte M, Schwab ME.

PLoS Biol. 2014 Jan;12(1):e1001763. doi: 10.1371/journal.pbio.1001763. Epub 2014 Jan 14. Erratum in: PLoS Biol. 2014 Feb;12(2):e1001818.

9.

DNA surface coating of calixarene-based nanoparticles: a sequence-dependent binding mechanism.

Rullaud V, Siragusa M, Cumbo A, Gygax D, Shahgaldian P.

Chem Commun (Camb). 2012 Dec 28;48(100):12186-8. doi: 10.1039/c2cc36859e.

PMID:
23147273
10.

Proteomic analysis of exosome-like vesicles derived from breast cancer cells.

Palazzolo G, Albanese NN, DI Cara G, Gygax D, Vittorelli ML, Pucci-Minafra I.

Anticancer Res. 2012 Mar;32(3):847-60.

PMID:
22399603
11.

An enzymatic method to determine γ-hydroxybutyric acid in serum and urine.

Hasan L, Jermann TM, Weber JM, Abrahamsson L, Sciotti MA, Böttcher M, Jöchle W, Gygax D, Scholer A.

Ther Drug Monit. 2011 Dec;33(6):757-65. doi: 10.1097/FTD.0b013e318239a41a.

PMID:
22105594
12.

Internal fixation of a fractured axis in an adult horse.

Gygax D, Fürst A, Picek S, Kummer M.

Vet Surg. 2011 Jul;40(5):636-40. doi: 10.1111/j.1532-950X.2011.00842.x. Epub 2011 May 4.

PMID:
21545463
13.

Development and characterization of an enzymatic method for the rapid determination of gamma hydroxybutyric acid.

Sciotti MA, Hasan L, Scholer A, Jermann TM, Weber JM, Gygax D.

Chimia (Aarau). 2010;64(11):793-8.

PMID:
21197843
15.

Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3.

Fasler-Kan E, Suenderhauf C, Barteneva N, Poller B, Gygax D, Huwyler J.

Brain Res. 2010 Oct 1;1354:15-22. doi: 10.1016/j.brainres.2010.07.077. Epub 2010 Aug 6.

PMID:
20692239
16.

Reverse protein arrays as novel approach for protein quantification in muscular dystrophies.

Escher C, Lochmüller H, Fischer D, Frank S, Reimann J, Walter MC, Ehrat M, Ruegg MA, Gygax D.

Neuromuscul Disord. 2010 May;20(5):302-9. doi: 10.1016/j.nmd.2010.02.017. Epub 2010 Mar 20.

PMID:
20304647
17.

Results and complications of a novel technique for primary castration with an inguinal approach in horses.

Kummer M, Gygax D, Jackson M, Bettschart-Wolfensberger R, Fürst A.

Equine Vet J. 2009 Jul;41(6):547-51.

PMID:
19803049
18.

A simple approach to improve the sensitivity of enzyme-linked immunosorbent assay: using the IMAPlate 5RC96 for result readout.

Spies P, Mueller R, Chen GJ, Gygax D.

Anal Biochem. 2010 Feb 1;397(1):48-52. doi: 10.1016/j.ab.2009.09.032. Epub 2009 Sep 22.

PMID:
19778520
19.

Infection with Mycobacterium avium subspecies avium in a 10 year old Freiberger mare.

Ryhner T, Wittenbrink M, Nitzl D, Zeller S, Gygax D, Wehrli Eser M.

Schweiz Arch Tierheilkd. 2009 Sep;151(9):443-7. doi: 10.1024/0036-7281.151.9.443.

20.

The effect of cadmium on brain cells in culture.

Gerspacher C, Scheuber U, Schiera G, Proia P, Gygax D, Di Liegro I.

Int J Mol Med. 2009 Sep;24(3):311-8.

PMID:
19639222
21.

Establishment of a miniaturized enzyme-linked immunosorbent assay for human transferrin quantification using an intelligent multifunctional analytical plate.

Spies P, Chen GJ, Gygax D.

Anal Biochem. 2008 Nov 1;382(1):35-9. doi: 10.1016/j.ab.2008.07.006. Epub 2008 Jul 16.

PMID:
18655766
22.

Comparison of the trimming procedure of six different farriers by quantitative evaluation of hoof radiographs.

Kummer M, Gygax D, Lischer C, Auer J.

Vet J. 2009 Mar;179(3):401-6. doi: 10.1016/j.tvjl.2007.10.029. Epub 2008 Mar 7.

PMID:
18314359
23.

Comparison of computer assisted surgery with conventional technique for treatment of abaxial distal phalanx fractures in horses: an in vitro study.

Rossol M, Gygax D, Andritzky-Waas J, Zheng G, Lischer CJ, Zhang X, Auer JA.

Vet Surg. 2008 Jan;37(1):32-42. doi: 10.1111/j.1532-950X.2007.00346.x.

PMID:
18199055
24.
25.

Efficacy, pharmacodynamics, and pharmacokinetics of CGP 51901, an anti-immunoglobulin E chimeric monoclonal antibody, in patients with seasonal allergic rhinitis.

Racine-Poon A, Botta L, Chang TW, Davis FM, Gygax D, Liou RS, Rohane P, Staehelin T, van Steijn AM, Frank W.

Clin Pharmacol Ther. 1997 Dec;62(6):675-90.

PMID:
9433396
26.

The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics.

Corne J, Djukanovic R, Thomas L, Warner J, Botta L, Grandordy B, Gygax D, Heusser C, Patalano F, Richardson W, Kilchherr E, Staehelin T, Davis F, Gordon W, Sun L, Liou R, Wang G, Chang TW, Holgate S.

J Clin Invest. 1997 Mar 1;99(5):879-87.

27.

Immunoassays in monitoring biotechnological drugs.

Gygax D, Botta L, Ehrat M, Graf P, Lefèvre G, Oroszlan P, Pfister C.

Ther Drug Monit. 1996 Aug;18(4):405-9.

PMID:
8857560
28.
29.

Comparative pharmacokinetics of free muramyl tripeptide phosphatidyl ethanolamine (MTP-PE) and liposomal MTP-PE.

Gay B, Cardot JM, Schnell C, van Hoogevest P, Gygax D.

J Pharm Sci. 1993 Oct;82(10):997-1001.

PMID:
8254500
30.

Pharmacokinetics of an HIV-1 gp120-specific chimeric antibody in patients with HIV-1 disease.

Schüpbach J, Günthard H, Fung MS, Liou RS, Botta L, Gowland P, Gordon W, Gygax D, Chang NT, Chang TW, et al.

Biotherapy. 1993;6(3):205-15.

PMID:
8292461
31.

Pharmacokinetics and immunomodulatory effects on monocytes during prolonged therapy with liposomal muramyltripeptide.

Landmann R, Obrist R, Denz H, Ludwig C, Frost H, Wesp M, Rordorf C, Towbin H, Gygax D, Tarcsay L, et al.

Biotherapy. 1993;7(1):1-12.

PMID:
8068481
32.

Optimization of a process for the production of (R)-2-hydroxy-4-phenylbutyric acid--an intermediate for inhibitors of angiotensin converting enzyme.

Schmidt E, Ghisalba O, Gygax D, Sedelmeier G.

J Biotechnol. 1992 Jul;24(3):315-27. Erratum in: J Biotechnol 1993 Nov;31(2):233.

PMID:
1368898
33.

Mouse/human chimeric anti-HIV-1 gp120 antibody to the principal neutralizing determinant: tolerability and pharmacokinetics in cynomolgus monkeys, Macaca fascicularis.

Liou RS, Fung MS, Zühlke U, Gudat F, McKinney S, Gordon W, Bee W, Botta L, Gygax D, Chang TW, et al.

Biotherapy. 1992;5(4):291-9.

PMID:
1283953
34.

Direct chemiluminescence immunoassay (CLIA) for muramyl tripeptide phosphatidyl-ethanolamine in plasma.

Gay B, Towbin H, Schnell C, Einsle K, Graf P, Gygax D.

J Biolumin Chemilumin. 1991 Apr-Jun;6(2):73-80.

PMID:
1882709
35.

Study to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei.

Gygax D, Ghisalba O, Treichler H, Nüesch J.

J Antibiot (Tokyo). 1990 Mar;43(3):324-6. No abstract available.

36.

D-ribulokinase from Klebsiella pneumoniae for continuous production of D-(-)-ribulose-5-phosphate.

Gygax D, Nachtegaal H, Ghisalba O, Lattmann R, Schär HP, Wandrey C, Streiff MB.

Appl Microbiol Biotechnol. 1990 Mar;32(6):621-6.

PMID:
1369262
37.

Immobilization of galactosyltransferase and continuous galactosylation of glycoproteins in a reactor.

Schneider R, Hammel M, Berger EG, Ghisalba O, Nueesch J, Gygax D.

Glycoconj J. 1990;7(6):589-600.

PMID:
2136355
38.

The enzymic utilization of sucrose in the synthesis of amylose and derivatives of amylose, using phosphorylases.

Waldmann H, Gygax D, Bednarski MD, Shangraw WR, Whitesides GM.

Carbohydr Res. 1986 Dec 1;157:c4-7. No abstract available.

PMID:
2949832

Supplemental Content

Support Center